Cart
sales@molnova.com
Br-Mmc
CAS No. 35231-44-8
Br-Mmc( 4-Bromomethyl-7-methoxycoumarin )
Catalog No. M24304 CAS No. 35231-44-8
Br-Mmc is used as a new fluorescence label for fatty acids. It is used for the determination of fatty acids by HPLC or TLC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBr-Mmc
-
NoteResearch use only, not for human use.
-
Brief DescriptionBr-Mmc is used as a new fluorescence label for fatty acids. It is used for the determination of fatty acids by HPLC or TLC.
-
DescriptionBr-Mmc is used as a new fluorescence label for fatty acids. It is used for the determination of fatty acids by HPLC or TLC.
-
In Vitro——
-
In Vivo——
-
Synonyms4-Bromomethyl-7-methoxycoumarin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number35231-44-8
-
Formula Weight269.09
-
Molecular FormulaC11H9BrO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C1C=C(CBr)C2=CC=C(OC)C=C2O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wolf JH, et al. 4-Bromomethyl-7-methoxycoumarin and analogues as derivatization agents for high-performance liquid chromatography determinations: a review. J Pharm Biomed Anal. 1992 Feb-Mar;10(2-3):99-107.
molnova catalog
related products
-
IL-1a (223-250) (hum...
IL-1a (223-250) (human)
-
1-(4-hydroxybenzyl)-...
Orchidble (Compound 9) is a kind of phenanthrene compound which can be isolated from the roots of Bletilla ochracea.
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
